Clinical studies have reported associations between serum inflammatory markers in the acute phase of ICH, mainly CCL2, CXCL10, IL-6, IL-11, CRP, fibrinogen, and CSF cytokines with hematoma expansion and early neurological decline [13,14]. Here, CCL2 is linked to hematoma.